Byteflies
7
0
0
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
14.3%
1 terminated/withdrawn out of 7 trials
80.0%
-6.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Clinical Utility of Reduced EEG Home Monitoring in Fenfluramine Titration for Dravet and LGS
Role: lead
EpiCare@Home Validation Study for Focal Onset Seizures
Role: lead
Advanced EEG Technology in Childhood Epilepsy
Role: collaborator
Sensor-Dot and Plug 'n Patch Study in Epilepsy
Role: collaborator
Multiple Sclerosis Prediction and Monitoring of Progression Study
Role: collaborator
Clinical Scenarios for Long-term Monitoring of Epileptic Seizures With a Wearable Biopotential Technology
Role: collaborator
Continuous Cardiorespiratory Monitoring in Cystic Fibrosis
Role: lead
All 7 trials loaded